Cite Filings / CLDI / 0001193125-23-205022

Feed Companies Filings Check

Sign in

425

Prospectus/Communication re Business Combination

Calidi Biotherapeutics, Inc. Filed 2023-08-07 Acc 0001193125-23-205022

Documents 1

425 Prospectus/Communication re Business Combination , d541284d425.htm

Around this filing

2023-08-16 425 Prospectus/Communication re Business Combination
2023-08-08 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2023-08-07 425 Prospectus/Communication re Business Combination
2023-08-04 EFFECT Notice of Effectiveness
2023-08-04 424B3 Prospectus
2023-08-03 CORRESP Correspondence Between Filers and SEC Staff
2023-07-18 425 Prospectus/Communication re Business Combination

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d541284d425.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…